Back
Theriva Biologics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
TOVX
Theriva Biologics
Last Price:
$1.24
Seasonality Move:
-12.89%
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight buying pressure.
Theriva Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.2 | Buy |
20-day SMA: | 1.27 | Sell |
50-day SMA: | 1.39 | Sell |
200-day SMA: | 2.92 | Sell |
8-day EMA: | 1.21 | Sell |
20-day EMA: | 1.27 | Sell |
50-day EMA: | 1.37 | Sell |
200-day EMA: | 3.48 | Sell |
Theriva Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 43.08 | Sell |
Chaikin Money Flow: | 2176 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.18 - 1.46) | Sell |
Bollinger Bands (100): | (1.19 - 1.65) | Sell |
Theriva Biologics Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
-
Theriva Biologics share price is 1.21 while TOVX 8-day simple moving average is 1.20, which is a Buy signal.
-
The stock price of TOVX is 1.21 while Theriva Biologics 20-day SMA is 1.27, which makes it a Sell.
-
Theriva Biologics 50-day simple moving average is 1.39 while TOVX share price is 1.21, making it a Sell technically.
-
TOVX stock price is 1.21 and Theriva Biologics 200-day simple moving average is 2.92, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
24
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a SellThe current Theriva Biologics [TOVX] share price is $1.21. The Score for TOVX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics Stock Info
Market Cap:
3.4M
Price in USD:
1.21
Share Volume:
6.5K
Theriva Biologics 52-Week Range
52-Week High:
12.28
52-Week Low:
1.03
Sell
24
Theriva Biologics (TOVX)
is a Sell
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?The Theriva Biologics stock price is 1.21 USD today.
-
Will TOVX stock go up or go down?Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators
-
Is Theriva Biologics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is overvalued.
Is Theriva Biologics Stock a Buy?
-
Theriva Biologics share price is 1.21 while TOVX 8-day exponential moving average is 1.21, which is a Sell signal.
-
The stock price of TOVX is 1.21 while Theriva Biologics 20-day EMA is 1.27, which makes it a Sell.
-
Theriva Biologics 50-day exponential moving average is 1.37 while TOVX share price is 1.21, making it a Sell technically.
-
TOVX stock price is 1.21 and Theriva Biologics 200-day simple moving average is 3.48, creating a Sell signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
-
TOVX Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Theriva Biologics is a Sell
-
Theriva Biologics Relative Strength Index (RSI) is 43.08, which suggest Theriva Biologics is oversold
-
The Bollinger Bands (25) for Theriva Biologics is (1.18 - 1.46), which suggest Theriva Biologics is a Sell
-
The Bollinger Bands (100) for Theriva Biologics is (1.19 - 1.65), which suggest Theriva Biologics is a Sell
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.